We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Trial Policies, Biomarkers To Reverse Drug Approval Drop
Clinical Trial Policies, Biomarkers To Reverse Drug Approval Drop
January 20, 2006
Congress, the FDA and industry are in the midst of pushing a number of initiatives to bolster falling drug approval rates, a prominent industry analyst says.